ImageneBio (IMA) Shares Outstanding (Diluted Average) (2021 - 2025)

ImageneBio has disclosed Shares Outstanding (Diluted Average) across 5 years of filings, most recently posting $3.8 million for Q3 2025.

• Shares Outstanding (Diluted Average) for Q3 2025 came in at $3.8 million, up 282.85% year-over-year; the trailing twelve-month figure through Sep 2025 was $3.8 million (up 282.85% YoY), and the FY2024 annual result was $48.3 million, up 15.63% from the prior year.
• Shares Outstanding (Diluted Average) came in at $3.8 million for Q3 2025 at ImageneBio, down from $48.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $48.3 million in Q1 2024 to a low of $994869.0 in Q3 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $36.2 million (2022), against an average of $31.9 million.
• Across the five-year window, Shares Outstanding (Diluted Average) plunged 97.49% in 2024 and surged 282.85% in 2025, its largest moves.
• ImageneBio's Shares Outstanding (Diluted Average) stood at $28.0 million in 2021, then gained by 29.32% to $36.2 million in 2022, then advanced by 15.33% to $41.7 million in 2023, then grew by 15.63% to $48.3 million in 2024, then sank by 92.11% to $3.8 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $3.8 million (Q3 2025), $48.3 million (Q2 2025), and $2.4 million (Q1 2025), per Business Quant data.